PoC Molecular Diagnostics Market: By Technology (PCR-based, Genetic Sequencing-based, Hybridization-based and Microarray-based), By Test Location (OTC and POC), By Application (Infectious Diseases, Oncology, Hematology, Prenatal Testing, Endocrinology and Other Applications), By End User (Decentralized Labs, Hospitals, Home-care, Assisted Living Healthcare Facilities and Other users) and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

The PoC Molecular Diagnostics Market was valued at USD 4,879.1 million in 2023 growing at a CAGR of 9.1% from 2024-2030. The market is fuelled by some of the key factors such as rising demand for rapid diagnostics, increasing prevalence of infectious diseases, technological advancements, and growing awareness of healthcare. The high cost of tests, Regulatory hurdles, and Limited test menu are the restraints that need to be addressed for the market growth. There is a significant opportunity for market growth which is the development of multiplex tests, integration with digital health technologies, and expansion into new applications. Focus on user-friendliness, miniaturization of devices, and point-of-need testing are the trends that help in the market growth. North America currently holds the dominant position & Asia Pacific region is expected to witness the fastest growth in the PoC molecular diagnostics market. Traditional laboratory-based molecular diagnostics often have long turnaround times, which can delay treatment decisions. PoC molecular diagnostics offer results in minutes, enabling faster and more effective treatment. The global burden of infectious diseases is high, and the demand for rapid and accurate diagnostics is growing. PoC molecular diagnostics can be used to diagnose a wide range of infectious diseases, including COVID-19, influenza, and sexually transmitted infections (STIs). Advancements in molecular diagnostics technologies, such as microfluidics and isothermal amplification, are leading to the development of smaller, faster, and more user-friendly PoC molecular diagnostic tests. There is a growing awareness of healthcare among the population, which is leading to an increased demand for self-testing and home healthcare products. PoC molecular diagnostics can be used for self-testing and home healthcare, which can improve access to diagnostics for people in remote areas or with limited healthcare resources.

Recent Developments in the PoC Molecular Diagnostics Market  

  • In May 2022, bioMérieux received De Novo FDA Authorization for its BIOFIRE Joint Infection (JI) Panel. This panel expands its portfolio with a wide range of assays for infectious diseases.
  • In May 2023, Siemens partnered with Unilabs, with an agreed value exceeding USD 200 million. This collaboration aimed to enhance point-of-care diagnostics and improve patient outcomes.

 

Global Poc Molecular Diagnostics Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

9.1%

Largest Market

North America

Fastest Growing Market

Asia-Pacific
PoC Molecular Diagnostics Market Dynamics

Multiplex PoC molecular diagnostic tests can detect multiple pathogens simultaneously, which can improve diagnostic accuracy and efficiency. PoC molecular diagnostic tests can be integrated with digital health technologies, such as telemedicine, to allow for remote monitoring and treatment. PoC molecular diagnostics can be used for a variety of applications beyond infectious disease testing, such as cancer diagnostics, pharmacogenomics, and personalized medicine. PoC molecular diagnostic tests are becoming increasingly user-friendly, making them easier to use by healthcare professionals and patients alike. PoC molecular diagnostic devices are becoming smaller and more portable, making them more convenient for use in a variety of settings. There is a growing trend towards point-of-need testing (PON testing), which refers to the use of diagnostic tests at the location where the patient needs care. PON testing can improve access to diagnostics in resource-limited settings. The PoC Molecular Diagnostics Market is a rapidly growing market with significant potential for future growth. The drivers mentioned above are expected to continue to propel the market forward, while the restraints and opportunities will shape the future of the market. PoC molecular diagnostic tests can be expensive, which can limit their adoption in low- and middle-income countries. The development and approval of new PoC molecular diagnostic tests can be a lengthy and expensive process. The number of PoC molecular diagnostic tests available is currently limited compared to traditional laboratory-based tests.

Global Poc Molecular Diagnostics Market Segmentation

By Technology
  • PCR-based
  • Genetic Sequencing-based
  • Hybridization-based
  • Microarray-based
By Test Location
  • OTC
  • POC
By Application
By End User
  • Decentralized Labs
  • Hospitals
  • Home-care
  • Assisted Living Healthcare Facilities
  • Other users

Frequently Asked Questions

The PoC Molecular Diagnostics Market was valued at USD 4,879.1 million in 2023 growing at a CAGR of 9.1%.

Rising demand for rapid diagnostics, increasing prevalence of infectious diseases, technological advancements, and growing awareness of healthcare

Asia-Pacific is the fastest-growing region in the PoC Molecular Diagnostics Market.

Focus on user-friendliness, miniaturization of devices, and point-of-need testing are the trends in the PoC molecular diagnostic market.

Multiplex tests, integration with digital health technologies, and expansion into new applications are opportunities in the PoC molecular diagnostic market.

Market research is segmented based on technology, application, and region.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies.
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market.
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenarios.
1. Executive Summary
2. Global PoC Molecular Diagnostics Market Introduction 
2.1.Global PoC Molecular Diagnostics Market  - Taxonomy
2.2.Global PoC Molecular Diagnostics Market  - Definitions
2.2.1.Technology
2.2.2.Test Location
2.2.3.Application
2.2.4.End User
2.2.5.Region
3. Global PoC Molecular Diagnostics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global PoC Molecular Diagnostics Market Analysis, 2019-2023 and Forecast 2024-2030
4.1.  Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global PoC Molecular Diagnostics Market  By Technology, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
5.1. PCR-based
5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Genetic Sequencing-based
5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Hybridization-based
5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Microarray-based
5.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6. Global PoC Molecular Diagnostics Market  By Test Location, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
6.1. OTC
6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. POC
6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
7. Global PoC Molecular Diagnostics Market  By Application, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
7.1. Infectious Diseases
7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Oncology
7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Hematology
7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Prenatal Testing
7.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Endocrinology
7.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
7.6. Other Applications
7.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.6.3. Market Opportunity Analysis 
8. Global PoC Molecular Diagnostics Market  By End User, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
8.1. Decentralized Labs
8.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Hospitals
8.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Home-care
8.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Assisted Living Healthcare Facilities
8.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Other users
8.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9. Global PoC Molecular Diagnostics Market  By Region, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10. North America PoC Molecular Diagnostics Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
10.1. Technology Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.PCR-based
10.1.2.Genetic Sequencing-based
10.1.3.Hybridization-based
10.1.4.Microarray-based
10.2.  Test Location Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.OTC
10.2.2.POC
10.3.  Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Infectious Diseases
10.3.2.Oncology
10.3.3.Hematology
10.3.4.Prenatal Testing
10.3.5.Endocrinology
10.3.6.Other Applications
10.4.  End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Decentralized Labs
10.4.2.Hospitals
10.4.3.Home-care
10.4.4.Assisted Living Healthcare Facilities
10.4.5.Other users
10.5.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11. Europe PoC Molecular Diagnostics Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
11.1. Technology Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.PCR-based
11.1.2.Genetic Sequencing-based
11.1.3.Hybridization-based
11.1.4.Microarray-based
11.2.  Test Location Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.OTC
11.2.2.POC
11.3.  Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Infectious Diseases
11.3.2.Oncology
11.3.3.Hematology
11.3.4.Prenatal Testing
11.3.5.Endocrinology
11.3.6.Other Applications
11.4.  End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Decentralized Labs
11.4.2.Hospitals
11.4.3.Home-care
11.4.4.Assisted Living Healthcare Facilities
11.4.5.Other users
11.5.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
12. Asia Pacific (APAC) PoC Molecular Diagnostics Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
12.1. Technology Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.PCR-based
12.1.2.Genetic Sequencing-based
12.1.3.Hybridization-based
12.1.4.Microarray-based
12.2.  Test Location Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.OTC
12.2.2.POC
12.3.  Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Infectious Diseases
12.3.2.Oncology
12.3.3.Hematology
12.3.4.Prenatal Testing
12.3.5.Endocrinology
12.3.6.Other Applications
12.4.  End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Decentralized Labs
12.4.2.Hospitals
12.4.3.Home-care
12.4.4.Assisted Living Healthcare Facilities
12.4.5.Other users
12.5.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13. Middle East and Africa (MEA) PoC Molecular Diagnostics Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
13.1. Technology Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.PCR-based
13.1.2.Genetic Sequencing-based
13.1.3.Hybridization-based
13.1.4.Microarray-based
13.2.  Test Location Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.OTC
13.2.2.POC
13.3.  Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Infectious Diseases
13.3.2.Oncology
13.3.3.Hematology
13.3.4.Prenatal Testing
13.3.5.Endocrinology
13.3.6.Other Applications
13.4.  End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Decentralized Labs
13.4.2.Hospitals
13.4.3.Home-care
13.4.4.Assisted Living Healthcare Facilities
13.4.5.Other users
13.5.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14. Latin America PoC Molecular Diagnostics Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
14.1. Technology Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.PCR-based
14.1.2.Genetic Sequencing-based
14.1.3.Hybridization-based
14.1.4.Microarray-based
14.2.  Test Location Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.OTC
14.2.2.POC
14.3.  Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Infectious Diseases
14.3.2.Oncology
14.3.3.Hematology
14.3.4.Prenatal Testing
14.3.5.Endocrinology
14.3.6.Other Applications
14.4.  End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Decentralized Labs
14.4.2.Hospitals
14.4.3.Home-care
14.4.4.Assisted Living Healthcare Facilities
14.4.5.Other users
14.5.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1. Abbott Laboratories
15.2.2. Danaher Corporation
15.2.3. Biomerieux Sa
15.2.4. Roche Diagnostics
15.2.5. Quidel
15.2.6. Meridian Bioscience
15.2.7. Mesa Biotech
15.2.8. Genepoc
15.2.9. DxNA
15.2.10. Atlas Genetics
15.2.11. Spartan Bioscience
15.2.12. Biocartis
15.2.13. Bayer Healthcare
15.2.14. Becton, Dickinson and Company (BD)
15.2.15. Bio-Rad Laboratories
15.2.16. Cepheid
15.2.17. Johnson & Johnson
15.2.18. OraSure Technologies
15.2.19. QuantuMDx Group
15.2.20. Randox Laboratories
15.2.21. Robert Bosch GmbH
15.2.22. Siemens AG
15.2.23. Sysmex Corp.
16. Research Methodology 
17. Appendix and Abbreviations 

 

  • Abbott Laboratories
  • Danaher Corporation
  • Biomerieux Sa
  • Roche Diagnostics
  • Quidel
  • Meridian Bioscience
  • Mesa Biotech
  • Genepoc
  • DxNA
  • Atlas Genetics
  • Spartan Bioscience
  • Biocartis
  • Bayer Healthcare
  • Becton, Dickinson and Company (BD)
  • Bio-Rad Laboratories
  • Cepheid
  • Johnson & Johnson
  • OraSure Technologies
  • QuantuMDx Group
  • Randox Laboratories
  • Robert Bosch GmbH
  • Siemens AG
  • Sysmex Corp.

Adjacent Markets